MX2022014277A - Metodos para una mejor administracion de agentes activos a tumores. - Google Patents

Metodos para una mejor administracion de agentes activos a tumores.

Info

Publication number
MX2022014277A
MX2022014277A MX2022014277A MX2022014277A MX2022014277A MX 2022014277 A MX2022014277 A MX 2022014277A MX 2022014277 A MX2022014277 A MX 2022014277A MX 2022014277 A MX2022014277 A MX 2022014277A MX 2022014277 A MX2022014277 A MX 2022014277A
Authority
MX
Mexico
Prior art keywords
methods
tumors
active agents
agents
better delivery
Prior art date
Application number
MX2022014277A
Other languages
English (en)
Inventor
Russell Frederick Ross
Original Assignee
Sorrento Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorrento Therapeutics Inc filed Critical Sorrento Therapeutics Inc
Publication of MX2022014277A publication Critical patent/MX2022014277A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Abstract

La presente invención se refiere a la administración de agentes a través de la piel. Los métodos para administrar agentes tales como agentes bioactivos se contemplan en la presente invención. Específicamente, se describen métodos para la administración dirigida de agentes a una o más áreas de la epidermis y, de esta manera, a uno o más tumores de cáncer.
MX2022014277A 2015-07-24 2018-01-08 Metodos para una mejor administracion de agentes activos a tumores. MX2022014277A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562196570P 2015-07-24 2015-07-24
US201562196578P 2015-07-24 2015-07-24

Publications (1)

Publication Number Publication Date
MX2022014277A true MX2022014277A (es) 2022-12-07

Family

ID=57885141

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018000166A MX2018000166A (es) 2015-07-24 2016-07-22 Metodos para una mejor administración de agentes activos a tumores.
MX2022014277A MX2022014277A (es) 2015-07-24 2018-01-08 Metodos para una mejor administracion de agentes activos a tumores.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018000166A MX2018000166A (es) 2015-07-24 2016-07-22 Metodos para una mejor administración de agentes activos a tumores.

Country Status (15)

Country Link
US (2) US10806913B2 (es)
EP (2) EP3925599A1 (es)
JP (1) JP7082041B2 (es)
KR (1) KR20180035209A (es)
CN (1) CN107921248A (es)
AU (3) AU2016297823B2 (es)
BR (1) BR112018001292A2 (es)
CA (1) CA2991455C (es)
DK (1) DK3325080T3 (es)
ES (1) ES2891523T3 (es)
HU (1) HUE056410T2 (es)
MX (2) MX2018000166A (es)
PL (1) PL3325080T3 (es)
RU (1) RU2719943C2 (es)
WO (1) WO2017019526A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE056410T2 (hu) * 2015-07-24 2022-02-28 Sorrento Therapeutics Inc Eljárások a hatóanyagok jobb bejuttatására a tumorokba
WO2017019535A2 (en) * 2015-07-24 2017-02-02 Kimberly-Clark Worldwide, Inc. Methods for lymphatic delivery of active agents
WO2018213588A1 (en) 2017-05-17 2018-11-22 Massachusetts Institute Of Technology Tissue anchoring articles
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
CA3066991A1 (en) 2017-07-10 2019-01-17 Basf Se Mixtures comprising an urease inhibitor (ui) and a nitrification inhibitor such as 2-(3,4-dimethyl-1h-pyrazol-1-yl)succinic acid (dmpsa) or 3,4-dimethyl pyrazolium glycolate (dmpg)
WO2019222570A1 (en) 2018-05-17 2019-11-21 Massachusetts Institute Of Technology Systems for electrical stimulation
EP3801464A4 (en) * 2018-05-31 2022-03-16 Sorrento Therapeutics, Inc. ANTI-LYMPHICAL SYSTEM-DIRECTED DRUG RELEASE METHODS
US20210308440A1 (en) * 2018-09-24 2021-10-07 L'oreal Device comprising microneedles for skin-coloring
IL293479A (en) 2019-12-05 2022-08-01 Sorrento Therapeutics Inc A method of treating cancer by administering an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic device
US20240090908A1 (en) 2021-01-22 2024-03-21 Sorrento Therapeutics, Inc. Device for microliter-scale lymphatic delivery of coronavirus vaccines and methods of use thereof
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
CN117916264A (zh) 2021-06-09 2024-04-19 索伦托药业有限公司 通过经由淋巴微针递送装置施用抗pd-1或抗pd-l1治疗剂来治疗癌症的方法
CA3228858A1 (en) 2021-08-18 2023-02-23 Russell F. Ross Therapeutic agents targeting the lymphatic system

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
NZ516582A (en) * 2000-06-01 2004-08-27 Watson Pharmaceuticals Inc Transdermal delivery of lasofoxifene
AU2002333554C1 (en) * 2001-09-12 2008-12-11 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same
EP1635876A4 (en) * 2003-06-13 2009-05-06 Becton Dickinson Co IMPROVED INTRADERMAL ADMINISTRATION OF BIOACTIVE AGENTS
BRPI0414014A (pt) 2003-08-26 2006-10-24 Becton Dickinson Co métodos para distribuição intradérmica de agentes terapêuticos
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
WO2006127962A2 (en) * 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
CA2612005C (en) * 2005-06-17 2013-10-29 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) * 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (zh) * 2010-04-27 2012-08-22 上海交通大学 台阶微针阵列的制备方法
MX336139B (es) 2010-04-28 2016-01-08 Kimberly Clark Co Dispositivos medicos para la entrega de arn de interferencia corta.
RU2585159C2 (ru) 2010-04-28 2016-05-27 Кимберли-Кларк Ворлдвайд, Инк. Устройство доставки лекарственного средства, применяемого при ревматоидном артрите
CA2796965C (en) 2010-04-28 2019-04-16 Kimberly-Clark Worldwide, Inc. Method for increasing permeability of an epithelial barrier
EP2563453B1 (en) 2010-04-28 2017-02-08 Kimberly-Clark Worldwide, Inc. Nanopatterned medical device with enhanced cellular interaction and method for its forming
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
RS59898B1 (sr) 2011-10-17 2020-03-31 Massachusetts Inst Technology Intraćelijsko davanje
CN104039382B (zh) 2011-10-27 2018-01-12 金伯利-克拉克环球有限公司 高粘度生物活性剂的经皮递送
KR101575039B1 (ko) * 2012-07-19 2015-12-07 (주)아모레퍼시픽 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치
JP6546091B2 (ja) * 2012-09-13 2019-07-17 アミール，アブラハム 皮膚増大（ｓｋｉｎａｕｇｍｅｎｔａｔｉｏｎ）のための送達デバイスおよび方法
AU2013318338B2 (en) 2012-09-21 2017-05-25 Intensity Therapeutics, Inc Method of treating cancer
CN103157178B (zh) * 2013-02-05 2014-12-31 北京化工大学 精确控制微针插入长度的印章式工具
US10183156B2 (en) 2013-02-28 2019-01-22 Sorrento Therapeutics, Inc. Transdermal drug delivery device
WO2014132239A1 (en) 2013-02-28 2014-09-04 Kimberly-Clark Worldwide, Inc. Drug delivery device
BR112015027608A2 (pt) 2013-05-23 2017-07-25 Kimberly Clark Co microagulhas com geometrias transversais de canal aberto melhoradas
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
WO2017019535A2 (en) * 2015-07-24 2017-02-02 Kimberly-Clark Worldwide, Inc. Methods for lymphatic delivery of active agents
HUE056410T2 (hu) * 2015-07-24 2022-02-28 Sorrento Therapeutics Inc Eljárások a hatóanyagok jobb bejuttatására a tumorokba

Also Published As

Publication number Publication date
MX2018000166A (es) 2018-03-26
CN107921248A (zh) 2018-04-17
EP3325080A2 (en) 2018-05-30
EP3325080B1 (en) 2021-09-01
AU2016297823A1 (en) 2018-02-15
CA2991455A1 (en) 2017-02-02
JP2018521755A (ja) 2018-08-09
EP3325080A4 (en) 2019-04-17
RU2018104102A3 (es) 2019-11-06
US20210052871A1 (en) 2021-02-25
RU2719943C2 (ru) 2020-04-23
EP3925599A1 (en) 2021-12-22
RU2018104102A (ru) 2019-08-27
DK3325080T3 (da) 2021-10-04
KR20180035209A (ko) 2018-04-05
AU2021200146A1 (en) 2021-03-18
ES2891523T3 (es) 2022-01-28
HUE056410T2 (hu) 2022-02-28
AU2016297823B2 (en) 2020-10-22
PL3325080T3 (pl) 2022-01-24
AU2021200146B2 (en) 2022-08-25
JP7082041B2 (ja) 2022-06-07
CA2991455C (en) 2023-10-10
WO2017019526A2 (en) 2017-02-02
BR112018001292A2 (pt) 2018-09-11
AU2022275397A1 (en) 2023-01-05
US20180193624A1 (en) 2018-07-12
US10806913B2 (en) 2020-10-20

Similar Documents

Publication Publication Date Title
MX2022014277A (es) Metodos para una mejor administracion de agentes activos a tumores.
PH12018502429A1 (en) Antibody molecules for cancer treatment
WO2017134302A3 (en) Targeted therapeutic agents and uses thereof
ZA201905488B (en) Tigit- and light-based chimeric proteins
AU2024202345A1 (en) Nucleic acid carriers and therapeutic methods of use
MX2022014634A (es) Metodos para la administracion linfatica de agentes activos.
NZ752526A (en) Pyrrolobenzodiazepine conjugates
MA40437A (fr) Méthodes de traitement du cancer faisant appel à des inhibiteurs de tigit et à des agents anticancéreux
PH12016500871A1 (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
PH12019502363A1 (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
EA201591925A1 (ru) Терапевтические композиции и их применение
PH12016502249A1 (en) Pladienolide pyridine compounds and methods of use
MX2017005861A (es) Metodos para el control transcripcional objetivo en regiones del super mejorador.
MX2019013808A (es) Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cancer.
MX2016007445A (es) Inhibidores de f1f0-atpasa de trifluorometil pirazolil guanidina y usos terapeuticos de los mismos.
MX2017002388A (es) Composiciones para fibras de queratina.
PH12016501838A1 (en) Compounds and their methods of use
MX2017009608A (es) Compuestos anticancerigenos.
MX2020000636A (es) Proteinas sinteticas y usos terapeuticos de las mismas.
NZ746011A (en) Glycoalkaloid combinations and various uses thereof
MX2018014135A (es) Tratamiento del dolor.
EA201992022A1 (ru) Терапевтическая рнк
MX2020002812A (es) Abx196 para usarse en el tratamiento del cancer de vejiga.
MA39718A (fr) Compositions et méthodes d'utilisation de celles-ci
EA201492019A1 (ru) Способы лечения рака с помощью липопептидов